International Journal of Clinical Microbiology
ISSN: Coming Soon
Current Issue
Volume No: 1 Issue No: 1
share this page

Review Article | Open Access
  • Available online freely | Peer Reviewed
  • Regulation of Expression of Reactive Oxygen Intermediates During Plasmodium Infection to Reduce Immunopathology Provides a Possible Antioxidant Adjuvant to Enhance Anti-Malarial Drug Therapy

    Mazen M.J. Al-Obaidi 1     Andrew W. Taylor-Robinson 2      

    1Department of Medical Microbiology, University of Malaya, 50603 Kuala Lumpur, Malaysia

    2School of Health, Medical & Applied Sciences, Central Queensland University, Brisbane, QLD 4000, Australia

    Abstract

    Malaria is a mosquito-transmitted infectious disease caused by intracellular protozoan parasites of the genus Plasmodium. In the absence of prompt and appropriate treatment contraction of primary infection by a human being often represents a medical emergency since it may progress rapidly to life-threatening complications. Exposure to parasites activates the immune system resulting in, among other effects, the release of reactive oxygen intermediates (ROI). This has the potential to induce oxidative damage, thereby causing cellular destruction, and hence to have a severe effect on vital organs of the body. Overexpression of ROI leads to immunosuppression and is a causal factor in the development of malaria-related disease symptoms. However, the body possesses various defence mechanisms, notably including the production of antioxidants, which are capable of reducing the cellular effects of ROI. Antioxidants are either sourced exogenously from the diet or synthesized through different intracellular mechanisms. Antioxidants that include glutathione peroxidase, catalase, EDTA and vitamin C suppress the initial production of ROI. Others such as uric acid, superoxide dismutase and vitamin E may also inhibit potentially damaging products of ROI metabolism. Current anti-malarial drugs often have damaging side-effects, as exemplified by memory impairment following treatment for cerebral malaria. Recent studies have explored the potential use of antioxidants alone or in combination with anti-malarials as a therapeutic means to negate Plasmodium-induced oxidative stress and its associated metabolic complications. It is indicated that when utilized in an adjuvant capacity antioxidants of natural and synthetic origin may improve anti-malarial therapy by causing less damage to the host during malaria infection.

    Received 21 Jun 2017; Accepted 19 Jul 2017; Published 14 Aug 2017;

    Academic Editor:Jianping Pan, Department of Clinical Medicine

    Checked for plagiarism: Yes

    Review by: Single-blind

    Copyright©  2017 Mazen M.J. Al-Obaidi et al

    License
    Creative Commons License    This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

    Competing interests

    The authors have declared that no competing interests exist.

    Citation:

    Mazen M.J. Al-Obaidi, Andrew W. Taylor-Robinson (2017) Regulation of Expression of Reactive Oxygen Intermediates During Plasmodium Infection to Reduce Immunopathology Provides a Possible Antioxidant Adjuvant to Enhance Anti-Malarial Drug Therapy. International Journal Of Clinical Microbiology - 1(1):8-15.
    Download as RIS, BibTeX, Text (Include abstract )
    DOIComing Soon

    Introduction

    Malaria is an infectious disease of vertebrates caused by intracellular protozoan parasites belonging to the genus Plasmodium, of which five species are capable of infecting humans 1. Transmission between hosts occurs via the bite of an infected female Anopheles mosquito 1, 2. Malaria is at present endemic in 110 countries and is found on every continent, bar Antarctica, but is confined to mainly tropical and sub-tropical regions 3, 4. Of the estimated global population of 7.3 billion people, 3.5-3.7 billion are at risk of contracting malaria 3, 5. In the absence of prompt diagnosis and appropriate treatment disease can escalate to life-threatening complications, such as cerebral and renal manifestations 6. It is routinely claimed that there are 300-500 million clinical cases worldwide annually 7. The 1-3 million deaths that result equate to a death every 10-30 seconds 8, 9. 90% of deaths are due to P. falciparum and occur principally in young children in sub-Saharan Africa.

    P. Falciparum Infection Stimulates Host Immunity

    The life cycle of P. falciparum includes a symptomless, non-pathogenic liver stage of 7-10 days duration followed by the invasion of aged erythrocytes by infective forms, merozoites, which heralds the start of an intraerythrocytic vegetative growth cycle that is responsible for the pathogenic manifestations of disease (Figure 1). Erythrocytes rupture once mature schizonts are produced, which occurs 46-48 hours after invasion. Every erythrocyte releases between 16-32 merozoite progeny, each of which may bind to and enter a new erythrocyte to initiate a further cycle of asexual replication 4.

    Figure 1. Schematic diagram showing the mechanisms of immunity against different life cycle stages of Plasmodium falciparum. * indicates those targeted immune responses in which reactive oxygen intermediates play an important role.
    Figure 1.

    The human immune response against malaria infection is complex and depends on different stages of the life cycle 10 (Figure 1). Specific cytokines are released from human peripheral blood mononuclear cells which may activate the host’s monocytes, CD4+ and CD8+ T lymphocytes, natural killer (NK) cells and neutrophils to react to liver stage and blood stage parasites 11. The immune mechanism to intraerythrocytic malaria parasites is not fully understood, yet a particular cytokine profile is known to be associated with protection that involves a pro-inflammatory response by CD4+ T cells of the helper (Th) 1 subset, with a prevalence of interferon (IFN)-γ, tumour necrosis factor (TNF)-α and interleukin (IL)-12 12, 13, 14. In contrast, the Th2 profile (notable for the production of IL-10, IL-5, IL-4 and transforming growth factor (TGF-β)) is noted to enhance severe conditions of the disease. However, since different immune responses act effectively at different stages of parasite elimination, there is no overall consensus on the respective pros and cons of these cytokine profiles 15, 16.

    P. Falciparum Infection Activates ROI

    Malaria infection activates the immune system resulting in the release of reactive oxygen intermediates (ROI) that induce oxidative damage which has the potential to kill parasite-infected hepatocytes and erythrocytes but also to cause cellular pathology 17. This triggers such severe effects on vital organs of the body as hepatomegaly, splenomegaly, endothelial and cognitive damage. ROI, together with reactive nitrogen intermediates (RNI) also linked with oxidative stress, are implicated in the development of systemic complications caused by malaria leading to the production of hydroxyl radicals in the liver that are thought to be a reason for the induction of oxidative stress and apoptosis 18. Additionally, erythrocytes infected with P. falciparum produce twice the concentration of hydroxyl radicals and hydrogen peroxide compared to uninfected erythrocytes 19. However, the body has various defence mechanisms to reduce the cellular effects of ROI including the production of antioxidants obtained either from the diet or synthesized via different intracellular mechanisms. Potential roles of an antioxidant are preventive or chain-breaking. Preventive antioxidants such as glutathione peroxidase, catalase, EDTA and vitamin C suppress the initial production of free radicals including ROI. So-called chain-breaking antioxidants like uric acid, superoxide dismutase and vitamin E inhibit damaging products of the ROI pathway 20. Thus, antioxidants of both natural and synthetic origin possess the potential to confer host-protective adjuvant effects on antimalarial therapy that may result in reduced immunopathology during malaria infection.

    Oxidative Stress: A Host Defence Mechanism

    The mechanisms of action of ROI and RNI involve reduction or elimination of parasite load (Figure 1), which is the process exploited by most anti-malaria drugs for their activity. These reactive intermediates have a great influence on immune responses by activating or inhibiting the action of certain transcription factors or cytokines and also by modifying pathways of programmed cell death 21. An elevated level of nitric oxide (NO) results in immunosuppression and is causally linked to the development of cerebral malaria 22. However, as free radicals NO metabolites contribute to the destruction of Plasmodium23, 24. Malarial pigment is one of the few parasite-derived molecules that are known to elicit production of NO. Haemozoin is a potent inducer of NO generation in macrophages via the action of nuclear factor (NF)-κB and extracellular signal regulated by kinase (ERK). Haemozoin is associated with the mediator of IFN-γ mRNA synthesis through the enzyme inducible nitric oxide synthase (iNOS). During the hepatic stage of infection, defence mechanisms are linked to the release of IFN-γ by NK cells and NO synthesis 25. Haemozoin not only induces NO but is also responsible for macrophage activation by processes that are partially dependent on NO 26 and on other ROI/RNI such as the superoxide radical and hydrogen peroxide 27.

    On a related theme, an elevated concentration of iNOS in human monocytes has not been linked with an exacerbation of malaria. Studies conducted on spleen cells from P. berghei-infected mice either resistant or susceptible to cerebral malaria suggested that the expression of cytokines and NO increases in cells of resistant animals compared to their susceptible counterparts 28. In addition, expression of a marker of TNF-α activity was also raised in resistant mice, suggesting that activation of macrophages is much greater in resistant animals 29. These findings corroborate radiometric assays used to quantify the anti-plasmodial effect of phagocytes. These prior studies showed that TNF-α increases the release of ROI by neutrophils infected by P. falciparum, which are toxic and contribute to the elimination of the parasite 30.

    Derived from host erythrocytes, haemoglobin is a potential source of free radical synthesis in malaria. The parasite’s utilization of this protein molecule as a source of amino acids to meet its nutritional requirements during the erythrocytic stage of its life cycle results in liberation of extensive amounts of haem into the circulation 31. However these haem groups induce intravascular oxidative stress due to the presence of Fe2+-associated groups which cause metabolic flux in erythrocytes and endothelial cells and facilitate the internalization of the parasite in tissues such as the brain and liver 32. Moreover, free haem can activate neutrophil migration and ROI/RNI production with the help of the inhibitory Gα protein-coupled receptor that further activates protein kinase C, thus enhancing the inflammatory response 33 and delaying apoptosis, thereby contributing to the immunosuppression induced by malaria infection 34. Recently, it was shown that a transient oxidative insult to wild-type erythrocytes prior to infection with P. falciparum promotes phenotypic characters associated with the protective traits of haemoglobinopathic and fetal erythrocytes 35. This implies abnormal host actin remodelling and reduced cytoadherence are steps in a malaria host-protective pathway initiated by the redox imbalance that is inherent to sickle cell trait and other common hereditary blood disorders.

    Of various cytokines examined, an increase in granulocyte-macrophage colony-stimulating factor (GM-CSF) has been correlated with a reduction of parasitaemia and with oxidative stress 13. GM-CSF is a cytokine that is known to have stimulatory action on granulocytes and macrophages and that helps to enhance the number and activity of both of these cells, working effectively to provide cellular immunity against blood stage malaria. Several studies have reported that administration of GM-CSF, individually or in combination with other factors, protects experimental models from infection. Similarly, mice lacking the ability to synthesize GM-CSF have an impaired anti-Plasmodium immune response. Such research suggests a possible relationship between GM-CSF and oxidative stress. IL-4 and GM-CSF receptors may be altered by lipid peroxidation products derived from haemozoin that are released upon rupture of parasitized erythrocytes. These include, for example, 4-hydroxynonenal (4-HNE). IL-4 and GM-CSF are activators of the differentiation of haemozoin-loaded monocytes into dendritic cells which can be inhibited by 4-HNE and is an important immunosuppressive mechanism in malaria 36. In immature dendritic cells this appears to be linked to expression of peroxisome proliferator-activated receptor gamma (PPAR-γ) by cells loaded with haemozoin after administration of 15 S-hydroxyeicosatetraenoic acid – which is a PPAR-γ ligand produced by haemozoin via peroxidation caused by haem – that prevents the differentiation of these cells 37. A relationship exists between GM-CSF and NO, illustrated by pre-treatment with GM-CSF and methionine encephalin (TGG) helping to protect mice from malaria. Conversely, for mice pre-treated with iNOS inhibitors the mortality rate is enhanced significantly, showing that the protection exerted by GM-CSF/TGG is at least partially due to NO.

    Effects of Malaria on ROI

    Both host and parasites are placed under oxidative stress during a malaria infection. ROI are multifunctional molecules associated with host defence, hormone biosynthesis, mitogenesis, necrosis, apoptosis and gene expression 38. Increased concentrations of ROI are produced during degradation of haemoglobin within the parasite and by activated neutrophils in the peripheral blood of the host. In cases of severe malaria, ROI are produced by parasite haemoglobin metabolism in erythrocytes, nicotinamide adenine dinucleotide phosphate oxidase in phagocytes, and iNOS in response to deficiency of arginine or cofactor tetrahydrobiopterin substrate. Plasma haemoglobin produced upon erythrocyte lysis can also catalyze the generation of ROI. Patients suffering from severe malaria have enhanced level of ROI products in their urine 39, reduced deformability of erythrocytes under shear stress and decreased α-tocopherol in erythrocyte membranes 40. ROI may bestow both both protective and pathological effects on the host during malaria. After administration of pro-oxidants, enhanced ROI production is directed against intra-erythrocytic parasites. The utility of ROI to the innate immune response was first investigated in phagocytic cells by examining ROI production by NADPH oxidases (NOX) followed by pathogen killing 41. During infection erythrocytes are exposed to continuous oxidative stress. Univalent reduction of oxygen occurs, resulting in generation of a series of highly reactive cytotoxic oxygen species such as superoxide, hydrogen peroxide and hydroxyl. This causes a wide spectrum of cell damage including inactivation of enzymes, lipid peroxidation, damage to DNA and modification of intracellular oxidation-reduction states 13.

    Effects of Antioxidants on Malaria

    Many protective mechanisms have evolved to reduce the harmful effects of free radicals on cells. These include antioxidants like glutathione (GSH) and also enzymes like glutathione-S-transferase (GST), superoxide dismutase (SOD) and catalase that catalyse the dismutation of hydrogen peroxideand superoxide anions to water at the expense of GSH 42. Reduced GSH is a tripeptide with an intracellular non-protein free sulfhydryl group, and is essential to overcome oxidative stress and thus to maintain the normal reduced state inside the cell. NADPH generated by glucose 6-phosphate dehydrogenase in the pentose phosphate pathway reduces oxidized glutathione. Cells with reduced levels of glucose 6-phosphate dehydrogenase are very prone to oxidative stress. Erythrocytes experience very acute stress because, without mitochondria, there is no other means of generating reducing power.

    Human erythrocytes are rich in membrane sulfhydryl groups which play a major role in maintenance of oxidation-reduction status of the cell. A greater concentration of sulfhydryl groups in oxidatively stressed erythrocytes occurs because of their reduced GST activity 43. A longer association of toxic agents with sulfhydryl groups due to the decrease in GST activity may lead to their intraerythrocytic accumulation 44. Reduced levels of SOD and catalase in blood samples taken from malaria-infected patients resulted in heightened susceptibility of the erythrocytes to cell damage.

    The current anti-malarial drugs of choice often have a harmful side-effect, such as reported in memory impairment after cerebral malaria. As a consequence, recent studies have aimed to use antioxidants, alone or in combination with anti-malarials, as a potential therapeutic method focused at reducing Plasmodium-induced oxidative stress and its associated complications 45. However, some anti-malarials act by triggering oxidative stress; hence, the practical application of this strategy often yields conflicting outcomes. In general, researched antioxidants are. The effects on Plasmodium parasites in vitro of the antioxidants desferroxamine, vitamins C and E, folate and N-acetylcystein have been studied by direct administration and as adjunct therapy alongside standard anti-malarial regimens. The therapeutic relevance of antioxidants in malaria treatment depends on the targeted aspect of malaria pathology 46.

    Conclusion

    Oxidative stress plays an important role in the pathophysiology of malaria. This multifactorial phenomenon showcases a key aspect of the complex and intricate host-parasite relationship. Currently prescribed anti-malarials frequently have damaging side-effects. Thus, recent research has targeted the use of antioxidants, in combination with anti-malarials or alone, as a potential therapeutic method aimed at reducing Plasmodium-induced oxidative stress and its associated pathology. Release of ROI and RNI is integrally involved in the process by which parasitaemia is reduced and represents the main mechanism by which most anti-malaria drugs act. These metabolites regulate immune responses by activating or inhibiting release of transcription factors and cytokines and even by regulating programmed cell death. However, overexpression of ROI results in immunosuppression, which, as a consequence, exacerbates disease. The use of antioxidants of both natural and synthetic origin provides the potential for improved adjuvantation of anti-malarial therapy that results in less damage to the host. Further research into this concept is required.

    Funding Source

    None to declare.

    References

    1.Singh B, Kim Sung L, Matusop A, Radhakrishnan A, Shamsul S S. (2004) A large focus of naturally acquired Plasmodium knowlesi infections in human beings. , Lancet 363, 1017-1024.
    2.Moya A, Font E. (2004) Evolution: From Molecules to Ecosystems. , OxfordUniversityPress,Oxford
    3.WHO. (2008) World Malaria Report 2008, World Health Organization. , Geneva
    4.J G Breman. (2009) Eradicating malaria. , Science Prog 92, 1-38.
    5.S I Hay, Guerra C, Tatem A, Noor A, Snow R. (2004) The global distribution and population at risk of malaria: past, present, and future. , Lancet Infect. Dis 4, 327-336.
    6.Trampus A, Matijat J, R P Igormuzloric. (2003) . , Severe malaria. Clin. Rev 7, 315-323.
    7.C A Guerra, P W Gikandi, A J Tatem, A M Noor, D L Smith. (2008) The limits and intensity of Plasmodium falciparum transmission: implications for malaria control and elimination worldwide. PLoS Med. 5, 38.
    8.MVI. (2017) The PATH Malaria Vaccine Initiative. Available from: URL:. http://www.malariavaccine.org/sites/www.malariavaccine.org/files/content/resource/files/mviCVIA_mvibackgrounder.pdf [Last accessed 20June2017]
    9.WHO. (2017) Malaria. Available from: URL:. http://www.who.int/mediacentre/factsheets/ fs094/en/ [Last accessed 20June2017]
    10.Holder A A. (1999) Malaria vaccines. , Proc. Natl. Acad. Sci. USA 99, 1167-1169.
    11.Doolan D L, H P Beck, M F Good. (1994) Evidence for limited activation of distinct CD4+ T cell subsets in response to the Plasmodium falciparum circumsporozoite protein in Papua New Guinea. Parasite Immunol. 16, 129-136.
    12.A W Taylor-Robinson, R S Phillips, Severn A, Moncada S, F Y Liew. (1993) . The role of Th1 and Th2 cells inarodentmalariainfection.Science; 260, 1931-1934.
    13.Percário S, D R Moreira, Gomes B A Q, Ferreira M E S, Gonçalves A C M. (2012) Oxidative stress in malaria. , Int. J. Mol. Sci 13, 16346-16372.
    14.Stevenson M M, M F Tam, S F Wolf, Sher A. (1995) IL-12-induced protection against blood-stage Plasmodium chabaudi requires IFN-γ and TNF-α and occurs via a nitric oxide-dependent mechanism. , J. Immunol 155, 2545-2556.
    15.B S Das, Nanda N K. (1999) Evidence for erythrocyte lipid peroxidation in acute falciparum malaria. , Trans. R. Soc. Trop. Med. Hyg 93, 8-62.
    16.C J Hemmer, H A Lehr, Westphal K, Unverricht M, Kratzius M. (2005) Plasmodium falciparum malaria: reduction of endothelial cell apoptosis in vitro. , Infect. Immun 73, 1764-1770.
    17.P G Kremsner, Greve B, Luckner D, Schmid D. (2000) Malaria anaemia in African children associated with high oxygen radical production. , Lancet 355, 40-41.
    18.Guha M, Kumar S, Choubey V, Maity P, Bandyopadhyay U. (2006) Apoptosis in liver during malaria: Role of oxidative stress and implication of mitochondrial pathway. , FASEB J 20, 439-449.
    19.Atamna H, Ginsburg H. (1993) Origin of reactive oxygen species in erythrocytes infected with Plasmodium falciparum. , Mol. Biochem. Parasitol 61, 231-234.
    20.Valko M, Leibfritz D, Moncol J, Cronin M, Mazur M. (2007) Free radicals and antioxidants in normal physiological functions and human disease. , Int. J. Biochem. Cell Biol 39, 44-84.
    21.M A Arruda, A G Rossi, Freitas M S de, Barja-Fidalgo C, A V Graça-Souza. (2004) Heme inhibits human neutrophil apoptosis: involvement of phosphoinositide 3-kinase, MAPK, and NF-κΒ. , J. Immunol 173, 2023-2030.
    22.Jaramillo M, D C Gowda, Radzioch D, Olivier M. (2003) Hemozoin increases IFN-γ-inducible macrophage nitric oxide generation through extracellular signal-regulated kinase- and NF-κ Β-dependent pathways. , J. Immunol 171, 4243-4253.
    23.A W Taylor-Robinson, Severn A, R S Phillips. (1996) Kinetics of nitric oxide production during infection and reinfection of mice with Plasmodium chabaudi. , Parasite Immunol 18, 425-430.
    24.A W Taylor-Robinson. (1997) Antimalarial activity of nitric oxide: cytostasis and cytotoxicity towards Plasmodium falciparum. , Biochem. Soc. Trans 25, 262.
    25.Saeftel M, Krueger A, Arriens S, Heussler V, Racz P. (2004) Mice deficient in interleukin-4 (IL-4) or IL-4 receptor α have higher resistance to sporozoite infection with Plasmodium berghei (ANKA) than do naive wild-type mice. , Infect. Immun 72, 322-331.
    26.Jaramillo M, Godbout M, Olivier M. (2005) Hemozoin induces macrophage chemokine expression through oxidative stress-dependent and -independent mechanisms. , J. Immunol 174, 475-484.
    27.Brinkmann V, S H Kaufmann, Simon M M, Fischer H. (1984) Role of macrophages in malaria: O2 metabolite production and phagocytosis by splenic macrophages during lethal Plasmodium berghei and self-limiting Plasmodium yoelii infection in mice. , Infect. Immun 44, 743-746.
    28.P S Hanum, Hayano M, Kojima S. (2003) Cytokine and chemokine responses in a cerebral malaria-susceptible or -resistant strain of mice to Plasmodium berghei ANKA infection: early chemokine expression in the brain. , Int. Immunol 15, 633-640.
    29.H P Syarifah, Masashi H, Somei K. (2002) Cytokine and chemokine responses in a cerebral malaria-susceptible or -resistant strain of mice to Plasmodium berghei ANKA infection: early chemokine expression in the brain. , Int. Immun 15, 633-640.
    30.L M Kumaratilake, Ferrante A, C M Rzepczyk. (1990) Tumor necrosis factor enhances neutrophil-mediated killing of Plasmodium falciparum. , Infect. Immun 58, 788-793.
    31.B J Foth, Zhang N, B K Chaal, S K, Preiser P R. (2011) Quantitative time-course profiling of parasite and host cell proteins in the human malaria parasite Plasmodium falciparum. , Mol. Cell. Proteomics 10, 110-006411.
    32.Kumar S, Bandyopadhyay U. (2005) Free heme toxicity and its detoxification systems in human. , Toxicol. Lett 157, 175-188.
    33.B N Porto, L S Alves, P L Fernández, T P Dutra, R T Figueiredo. (2007) Heme induces neutrophil migration and reactive oxygen species generation through signaling pathways characteristic of chemotactic receptors. , J. Biol. Chem 282, 24430-24436.
    34.Taramelli D, Recalcati S, Basilico N, Olliaro P, Cairo G. (2000) Macrophage preconditioning with synthetic malaria pigment reduces cytokine production via heme iron-dependent oxidative stress. , Lab. Invest 80, 1781-1788.
    35.Cyrklaff M, Srismith S, Nyboer B, Burda K, Hoffmann A. (2016) Oxidative insult can induce malaria-protective trait of sickle and fetal erythrocytes. , Nat. Commun 7, 13401.
    36.Skorokhod O, Schwarzer E, Grune T, Arese P. (2005) Role of 4-hydroxynonenal in the hemozoin-mediated inhibition of differentiation of human monocytes to dendritic cells induced by GM-CSF/IL-4. , Biofactors 24, 283-289.
    37.O A Skorokhod, Alessio M, Mordmüller B, Arese P, Schwarzer E. (2004) Hemozoin (malarial pigment) inhibits differentiation and maturation of human monocyte-derived dendritic cells: a peroxisome proliferator-activated receptor-gamma-mediated effect. , J. Immunol 173, 4066-4074.
    38.Sumimoto H. (2008) Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species. , FEBS J 275, 3249-3277.
    39.Charunwatthana P, Abul Faiz M, Ruangveerayut R, Maude R J, Rahman M R. (2009) N-acetylcysteine as adjunctive treatment in severe malaria: a randomized double blinded placebo controlled-clinical trial. , Crit. Care Med 37, 516-522.
    40.M J Griffiths, Ndungu F, Baird K L, Muller D P, Marsh K. (2001) Oxidative stress and erythrocyte damage in Kenyan children with severe Plasmodium falciparum malaria. , Br. J. Haematol 113, 486-491.
    41.E M Ha, C T Oh, Y S Bae, W J Lee. (2005) A direct role for dual oxidase in Drosophila gut immunity. , Science 310, 847-850.
    42.O G Rinola, J A Olaniyi, M O Akiibinu. (2008) Evaluation of antioxidant levels and trace elements status in Nigerian sickle cell diseases patients with plasmodium parasitaemia. , Pak. J. Nutr 7, 766-769.
    43.P K Maurya, Kumar P, Chandra P. (2015) Biomarkers of oxidative stress in erythrocytes as a function of human age. , World J. Methodol 5, 216-222.
    44.Bernabucci U, Ronchi B, Lacetera U, Nardone A. (2002) Markers of oxidative status in plasma and erythrocyte of transition dairy cows during hot season:. , J. Dairy Sci 85, 2173-2179.
    45.H C Ackerman, S D Beaudry, R M Fairhurst. (2009) Antioxidant therapy: reducing malaria severity?. , Crit. Care Med 37, 758-760.
    46.M B Isah, M A Ibrahim. (2014) The role of antioxidants treatment on the pathogenesis of malarial infections: a review. , Parasitol. Res 113, 801-809.